Standard Family Office’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-402
Closed -$91K 34
2022
Q3
$91K Buy
+402
New +$97.4K 0.04% 76
2021
Q3
Sell
-275
Closed -$67K 92
2021
Q2
$67K Hold
275
0.01% 223
2021
Q1
$68K Hold
275
0.02% 229
2020
Q4
$63K Buy
+275
New +$63.4K 0.02% 244

Other funds holding AMGN

Standard Family Office's AMGN Position: Q4 2022 in Review

Standard Family Office sold out of Amgen (AMGN) in Q4 2022, closing a stake of 402 shares — an estimated $91K sold.

Standard Family Office first reported a position in AMGN in Q4 2020 and held it in 4 quarters. The position peaked at $91K in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Standard Family Office reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 402 Amgen shares in Q4 2022, an estimated $91K.
  • Standard Family Office first reported a position in Amgen in Q4 2020 and held it in 4 quarters.
  • Standard Family Office's Amgen position peaked at $91K in Q3 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.